Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity
Skin cancer risk in BRCA1/2 mutation carriers
Working with a functional medicine clinician, Jasmine underwent gut microbiome testing, which revealed dysbiosis and low butyrate production
Features: Minimizes pigmentation: Formulated with the dream team of kojic acid, l-glutathione, and alpha-arbutin, the Kojic Acid Daily Syndet Soap helps reduce pigmentation and fight sunspots
More specifically, Semaglutide and Tirzepatide work together to support weight loss by controlling appetite and improving glycemic control
dont get enough magnesium from their diet